Latest News

(September 12, 2024): The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. For a comprehensive list of recent updates, please see What’s New in the Guidelines. The updated Sections are outlined below.  New Section Added to the Guidelines  Sections With Key Updates  Sections…

The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated.   Mycobacterium avium Complex  These guidelines are published in an electronic format and updated as changes in prevention and treatment science occurs. All updates are developed by the subject matter groups listed in Appendix B. Guideline updates are reviewed…

July 29, 2024: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated.   Leishmaniasis -Updated information on prevalence, including transmission in the United States. -Updated information on the use of polymerase chain reaction, or PCR, and serological tests for the diagnosis of leishmanial diseases. -Updated treatment regimens for each of the…

July 9, 2024: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV have been updated. These updates include new recommendations related to anal cancer screening and treatment.   Human Papillomavirus  These guidelines are published in an electronic format and updated as relevant changes in prevention and treatment recommendations occur. All updates…

June 4, 2024: CDC published clinical guidelines on counseling patients regarding doxycycline post-exposure prophylaxis (or doxy PEP) for bacterial sexually transmitted infection (STI) prevention. Doxy PEP has proven to reduce the risk of getting a bacterial STI for gay, bisexual, and other men who have sex with men and transgender women at increased risk for these…

The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV is published in an electronic format and updated as relevant changes in prevention and treatment recommendations occur.  All updates are developed by the subject matter groups listed in Appendix B. (Changes in group composition also are posted regularly.) These updates are…

February 27, 2024: The Department of Health and Human Services Guidelines Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (the Panel) has developed recommendations for the use of statin therapy in people with HIV, in collaboration with representatives from the American College of Cardiology (ACC), the American Heart Association (AHA),…

September 25, 2023: The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the updated sections are summarized below:  Syphilis  Tables 4, 5, and 6  For a list of recent updates, please see What’s New in the Guidelines. To view or download…

August 3, 2023: The Panel on Opportunistic Infections in Children with and Exposed to HIV (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV. Highlights from the updated sections are summarized below:  Introduction Cytomegalovirus For a list of recent updates, please see What’s New in the Guidelines. To…

July 24, 2023: The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the updated sections are summarized below:  Mpox (Monkeypox) For a list of recent updates, please see What’s New in the Guidelines. To view or download the guidelines,…